$LEXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LEXICON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in LEXICON PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,500 | 0 | 18,266 | 15.8 K to 18.3 K (+15.86 %) |
| Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 8,390 | 0 | 25,170 | |
| Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 10,836 | 0 | 21,671 | |
| Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 16.45 | 5,258 | 86,494 | 20,767 | 26 K to 20.8 K (-20.20 %) |
| Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 8,390 | 0 | 26,025 | 17.6 K to 26 K (+47.58 %) |
| Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 10,836 | 0 | 17,635 | 6.8 K to 17.6 K (+159.38 %) |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 0.00 | 11,960 | 0 | 11,960 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 14.44 | 47,860 | 691,098 | 47,860 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 5,080 | 0 | 5,080 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 14.44 | 11,850 | 171,114 | 11,850 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 0.00 | 10,370 | 0 | 10,370 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 14.44 | 41,470 | 598,827 | 41,470 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | A | 0.00 | 9,990 | 0 | 9,990 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | A | 14.44 | 39,960 | 577,022 | 39,960 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 0.00 | 10,340 | 0 | 10,340 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 14.44 | 41,370 | 597,383 | 41,370 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 0.00 | 21,450 | 0 | 21,450 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 14.44 | 85,780 | 1,238,663 | 85,780 | |
| Jun 08 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 6.23 | 1,500 | 9,345 | 17,399 | |
| Jun 08 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 15.00 | 1,500 | 22,500 | 15,946 | 17.4 K to 15.9 K (-8.60 %) |
| Jun 08 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 6.23 | 1,500 | 9,345 | 17,446 | 15.9 K to 17.4 K (+9.41 %) |
| May 23 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 6.23 | 6,000 | 37,380 | 18,899 | |
| May 23 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 13.00 | 6,000 | 78,000 | 15,946 | 21.9 K to 15.9 K (-27.34 %) |
| May 23 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 6.23 | 6,000 | 37,380 | 21,946 | 15.9 K to 21.9 K (+37.63 %) |
| May 16 2016 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 12.24 | 100,000 | 1,224,000 | 100,000 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Grant | A | 0.00 | 1,432 | 0 | 9,057 | 7.6 K to 9.1 K (+18.78 %) |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Grant | A | 0.00 | 1,432 | 0 | 9,199 | 7.8 K to 9.2 K (+18.44 %) |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Grant | A | 0.00 | 1,432 | 0 | 9,057 | 7.6 K to 9.1 K (+18.78 %) |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Grant | A | 0.00 | 1,432 | 0 | 9,771 | 8.3 K to 9.8 K (+17.17 %) |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Grant | A | 0.00 | 1,432 | 0 | 9,057 | 7.6 K to 9.1 K (+18.78 %) |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,432 | 0 | 9,057 | 7.6 K to 9.1 K (+18.78 %) |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Grant | A | 0.00 | 1,432 | 0 | 23,342 | 21.9 K to 23.3 K (+6.54 %) |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
| May 02 2016 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Grant | A | 0.00 | 1,432 | 0 | 9,057 | 7.6 K to 9.1 K (+18.78 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 5,807 | 0 | 17,421 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,929 | 0 | 5,857 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,428 | 0 | 2,429 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,785 | 0 | 0 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 9.07 | 3,815 | 34,602 | 39,393 | 43.2 K to 39.4 K (-8.83 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 5,807 | 0 | 43,208 | 37.4 K to 43.2 K (+15.53 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,929 | 0 | 37,401 | 34.5 K to 37.4 K (+8.50 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,428 | 0 | 34,472 | 32 K to 34.5 K (+7.58 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,785 | 0 | 32,044 | 29.3 K to 32 K (+9.52 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 5,271 | 0 | 15,814 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 2,679 | 0 | 5,357 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 2,357 | 0 | 2,357 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Payment of Exercise | F | 9.07 | 4,754 | 43,119 | 35,200 | 40 K to 35.2 K (-11.90 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 5,271 | 0 | 39,954 | 34.7 K to 40 K (+15.20 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 2,679 | 0 | 34,683 | 32 K to 34.7 K (+8.37 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 2,357 | 0 | 32,004 | 29.6 K to 32 K (+7.95 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 2,500 | 0 | 29,647 | 27.1 K to 29.6 K (+9.21 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,550 | 0 | 13,650 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,821 | 0 | 5,643 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 1,857 | 0 | 0 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 9.07 | 4,357 | 39,518 | 15,766 | 20.1 K to 15.8 K (-21.65 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,550 | 0 | 20,123 | 15.6 K to 20.1 K (+29.22 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,821 | 0 | 15,573 | 12.8 K to 15.6 K (+22.12 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,500 | 0 | 12,752 | 10.3 K to 12.8 K (+24.39 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 1,857 | 0 | 10,252 | 8.4 K to 10.3 K (+22.12 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 10,835 | 0 | 32,507 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 9.07 | 4,036 | 36,607 | 6,799 | 10.8 K to 6.8 K (-37.25 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 10,835 | 0 | 10,835 | 0 to 10.8 K |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,667 | 0 | 8,004 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,339 | 0 | 2,679 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 857 | 0 | 857 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 965 | 0 | 0 | |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 9.07 | 1,626 | 14,748 | 15,946 | 17.6 K to 15.9 K (-9.25 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,667 | 0 | 17,572 | 14.9 K to 17.6 K (+17.89 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,339 | 0 | 14,905 | 13.6 K to 14.9 K (+9.87 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 857 | 0 | 13,566 | 12.7 K to 13.6 K (+6.74 %) |
| Mar 02 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 965 | 0 | 12,709 | 11.7 K to 12.7 K (+8.22 %) |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 8,300 | 0 | 8,300 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 8.20 | 19,360 | 158,752 | 19,360 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | A | 0.00 | 16,340 | 0 | 16,340 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | A | 8.20 | 65,340 | 535,788 | 65,340 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 0.00 | 16,910 | 0 | 16,910 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 8.20 | 67,640 | 554,648 | 67,640 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 0.00 | 17,980 | 0 | 17,980 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 8.20 | 71,940 | 589,908 | 71,940 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 0.00 | 33,560 | 0 | 33,560 | |
| Feb 16 2016 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 8.20 | 134,230 | 1,100,686 | 134,230 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 18,691 | 0 | 53,376 | 34.7 K to 53.4 K (+53.89 %) |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Grant | A | 0.00 | 18,691 | 0 | 54,376 | 35.7 K to 54.4 K (+52.38 %) |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Grant | A | 0.00 | 18,691 | 0 | 53,376 | 34.7 K to 53.4 K (+53.89 %) |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Grant | A | 0.00 | 18,691 | 0 | 53,376 | 34.7 K to 53.4 K (+53.89 %) |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Grant | A | 0.00 | 18,691 | 0 | 53,376 | 34.7 K to 53.4 K (+53.89 %) |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Grant | A | 0.00 | 18,691 | 0 | 58,376 | 39.7 K to 58.4 K (+47.10 %) |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Grant | A | 0.00 | 18,691 | 0 | 153,376 | 134.7 K to 153.4 K (+13.88 %) |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
| Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Grant | A | 0.00 | 18,691 | 0 | 53,376 | 34.7 K to 53.4 K (+53.89 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 19,750 | 0 | 59,250 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 17,500 | 0 | 35,000 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 13,000 | 0 | 13,000 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 0.94 | 18,266 | 17,170 | 58,767 | 77 K to 58.8 K (-23.71 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 19,750 | 0 | 77,033 | 57.3 K to 77 K (+34.48 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 17,500 | 0 | 57,283 | 39.8 K to 57.3 K (+43.99 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 13,000 | 0 | 39,783 | 26.8 K to 39.8 K (+48.54 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | NORTHCOTT JOHN | VP, Marketing, Comm ... | Option Exercise | M | 0.00 | 11,250 | 0 | 33,750 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | NORTHCOTT JOHN | VP, Marketing, Comm ... | Payment of Exercise | F | 0.94 | 3,015 | 2,834 | 8,235 | 11.3 K to 8.2 K (-26.80 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | NORTHCOTT JOHN | VP, Marketing, Comm ... | Buy | M | 0.00 | 11,250 | 0 | 11,250 | 0 to 11.3 K |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 18,750 | 0 | 56,250 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 16,500 | 0 | 33,000 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 17,500 | 0 | 17,500 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 16,250 | 0 | 0 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Payment of Exercise | F | 0.94 | 25,318 | 23,799 | 190,032 | 215.4 K to 190 K (-11.76 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 18,750 | 0 | 215,350 | 196.6 K to 215.4 K (+9.54 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 16,500 | 0 | 196,600 | 180.1 K to 196.6 K (+9.16 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 17,500 | 0 | 180,100 | 162.6 K to 180.1 K (+10.76 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 16,250 | 0 | 162,600 | 146.4 K to 162.6 K (+11.10 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 9,375 | 0 | 28,125 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,000 | 0 | 12,000 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,750 | 0 | 6,750 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 0.94 | 9,041 | 8,499 | 82,225 | 91.3 K to 82.2 K (-9.91 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 9,375 | 0 | 91,266 | 81.9 K to 91.3 K (+11.45 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,000 | 0 | 81,891 | 75.9 K to 81.9 K (+7.91 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,750 | 0 | 75,891 | 69.1 K to 75.9 K (+9.76 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 7,500 | 0 | 69,141 | 61.6 K to 69.1 K (+12.17 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 20,500 | 0 | 61,500 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 17,000 | 0 | 34,000 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 19,500 | 0 | 19,500 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 18,750 | 0 | 0 | |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 0.94 | 20,718 | 19,475 | 204,821 | 225.5 K to 204.8 K (-9.19 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 20,500 | 0 | 225,539 | 205 K to 225.5 K (+10.00 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 17,000 | 0 | 205,039 | 188 K to 205 K (+9.04 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 19,500 | 0 | 188,039 | 168.5 K to 188 K (+11.57 %) |
| Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 18,750 | 0 | 168,539 | 149.8 K to 168.5 K (+12.52 %) |
| Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 0.89 | 1,213,600 | 1,080,104 | 1,213,600 | |
| Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 0.00 | 303,400 | 0 | 303,400 | |
| Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.89 | 174,300 | 155,127 | 174,300 | |
| Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 74,700 | 0 | 74,700 | |
| Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP, Safety and PV ... | Option Exercise | A | 0.89 | 509,600 | 453,544 | 509,600 | |
| Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP, Safety and PV ... | Option Exercise | A | 0.00 | 127,400 | 0 | 127,400 | |
| Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Pharmaceutical ... | Option Exercise | A | 0.89 | 590,400 | 525,456 | 590,400 |